Predictors for Successful Mobilization of Peripheral Blood Progenitor Cells with ESHAP+G-CSF in Patients with Pretreated Non-Hodgkin's Lymphoma

Barlogie, 2004, Treatment of multiple myeloma, Blood, 103, 20, 10.1182/blood-2003-04-1045 Schmitz, 2007, Autologous stem cell transplantation in lymphoma, Semin Hematol, 44, 234, 10.1053/j.seminhematol.2007.08.007 Majhail, 2006, Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma, Biol Blood Marrow Transplant, 12, 1065, 10.1016/j.bbmt.2006.06.006 Gratwohl, 2001, European Group for Blood and Marrow Transplantation. Hematopoietic stem cell transplantation activity in Europe 1999, Bone Marrow Transplant, 27, 899, 10.1038/sj.bmt.1702995 Ergene, 2007, Factors influencing engraftment in autologous peripheral hematopoetic stem cell transplantation (PBSCT), Transfus Apher Sci, 36, 23, 10.1016/j.transci.2006.08.009 Ketterer, 1998, High CD34+ cell counts decrease hematological toxicity of autologous peripheral blood progenitor cell transplantation, Blood, 91, 3148, 10.1182/blood.V91.9.3148 Haas, 1994, Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma, Blood, 83, 3787, 10.1182/blood.V83.12.3787.3787 Kiss, 1997, Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation, Bone Marrow Transplant, 19, 303, 10.1038/sj.bmt.1700671 Assouline, 2006, Comparison of peripheral blood progenitor cell yield from standard chemotherapy used in the treatment of lymphoid malignancies and high-dose cyclophosphamide: a retrospective review of 141 patients, Transfusion, 46, 174, 10.1111/j.1537-2995.2006.00695.x Pavone, 2002, Mobilization of peripheral blood stem cells with highdose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma, Bone Marrow Transplant, 29, 285, 10.1038/sj.bmt.1703364 Lee, 2005, ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSF, Bone Marrow Transplant, 35, 449, 10.1038/sj.bmt.1704798 Watts, 2000, ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g/m2 and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients, Br J Cancer, 82, 278, 10.1054/bjoc.1999.0915 Ikeda, 2004, Factors for PBPC collection efficiency and collection predictors, Transfus Apher Sci, 31, 245, 10.1016/j.transci.2004.09.008 Chapple, 1998, Peripheral blood CD34+ cell count reliably predicts autograft yield, Bone Marrow Transplant, 22, 125, 10.1038/sj.bmt.1701308 Ketterer, 1998, Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies, Br J Haematol, 103, 235, 10.1046/j.1365-2141.1998.00960.x Moskowitz, 1998, Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma, Clin Cancer Res, 4, 311 Zimmerman, 1999, Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphoma, J Clin Apheresis, 14, 31, 10.1002/(SICI)1098-1101(1999)14:1<31::AID-JCA6>3.0.CO;2-C Petit, 1999, Feasibility of ESHAP + G-CSF as peripheral blood hematopoietic progenitor cell mobilisation regimen in resistant and relapsed lymphoma: a single-center study of 22 patients, Leukemia Lymphoma, 34, 119, 10.3109/10428199909083387 Elliott, 1996, When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34+ cell yield by preceding day CD34+ concentration in peripheral blood, J Clin Oncol, 4, 970, 10.1200/JCO.1996.14.3.970 Shipp, 1999, International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury, J Clin Oncol, 17, 423, 10.1200/JCO.1999.17.1.423 Velasquez, 1994, ESHAP–an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study, J Clin Oncol, 12, 1169, 10.1200/JCO.1994.12.6.1169 Koumakis, 1996, Predictive factors affecting mobilization and peripheral blood stem cell collection using single apheresis for rescuing patients after high-dose chemotherapy in various malignancies, Bone Marrow Transplant, 18, 1065 Drake, 1997, Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system, Br J Haematol, 98, 745, 10.1046/j.1365-2141.1997.2743091.x Strehl, 2003, High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma: a meta-analysis, Haematologica, 88, 1304